Skip to main content
logo
D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea flag South Korea · Delayed Price · Currency is KRW
42,800
-1,800 (-4.04%)
Sep 22, 2026, 3:30 PM KST

D&D Pharmatech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,961,8503,996,552513,608---
Market Cap Growth
9.29%678.13%----
Enterprise Value
1,924,0513,964,719494,061---
Last Close Price
42800.0091800.0012150.00---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
713.29929.9544.91---
PB Ratio
14.6350.607.38---
P/TBV Ratio
18.8781.3314.45---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-922.5443.20---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.860.080.140.151.470.32
Net Debt / Equity Ratio
-0.28-0.34-0.29-0.140.09-0.23
Net Debt / EBITDA Ratio
1.160.941.040.83-0.030.51
Net Debt / FCF Ratio
1.491.260.910.82-0.030.61
Asset Turnover
0.010.040.130.220.000.01
Quick Ratio
23.406.433.202.280.471.14
Current Ratio
27.219.413.582.610.611.22
Return on Equity (ROE)
-20.48%-32.29%-47.25%9.29%-174.72%-43.71%
Return on Assets (ROA)
-11.25%-21.79%-17.70%-9.75%-24.89%-19.70%
Return on Invested Capital (ROIC)
-49.41%-66.86%-51.56%-30.26%-108.81%-65.13%
Return on Capital Employed (ROCE)
-12.00%-36.90%-29.00%-18.80%-177.30%-41.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.10%-0.59%-5.57%---
FCF Yield
-1.27%-0.53%-4.32%---
Buyback Yield / Dilution
-2.89%-8.33%-8.08%-16.38%2.05%-12.66%